Skip to main content
Fig. 2 | The Journal of Headache and Pain

Fig. 2

From: European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 2: flunarizine

Fig. 2

PRISMA flowchart of the study. The systematic search yielded a total of 10,826 unique records. Title and abstract screening resulted in 1276 records potentially eligible, and after full‐text review 5 records proved eligible. Records that did not describe full‐text peer‐reviewed reports of randomized placebo-controlled trials in participants ≥ 18 years old of flunarizine in migraine prevention were excluded

Back to article page